$HDSN

HUDSON TECHNOLOGIES INC /NY (HDSN): Results of Operations and Financial Condition

HUDSON TECHNOLOGIES INC /NY (HDSN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622080d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 HUDSON TECHNOLOGIES REPORTS SECOND quarter 2026 reSults Second quarter revenue grew 8% driven by strong volume Posts trailing twelve month double-digit volume growth Operations fully restored at tornado impacted facility

Original reporting
Published Aug 5, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$HDSN
Bearish
high confidence
Mentioned
$HDSN
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$HDSNBearishMed
01

Why it matters

Q2 results show revenue growth driven by volume but lower selling prices, while gross margin fell and SG&A rose due to ERP optimization and legal expenses. The company revised its full-year 2026 gross margin target downward to low-to-mid 20s, citing continued subdued refrigerant pricing and inflationary pressures through year-end. It also announced an intention to partner with Icorium to commercialize extractive distillation technology to improve purification efficiency and working capital conversion.

02

Market read

Traders can update valuation and positioning based on the explicit gross margin guide reset and the disclosed drivers of profitability (pricing, fuel inflation, SG&A).

03

What to watch

The Icorium partnership could improve recovered refrigerant conversion efficiency, but the filing provides no financial impact timing or quantified benefits, leaving near-term guidance as the dominant signal.

Relevance 7/10Novelty 8/10Timing: after-hours filing and same-day 5:00 p.m. ET conference call

Background

Hudson Technologies is a refrigerant reclaimer and separation-technology provider serving HVACR aftermarket service, with exposure to refrigerant market pricing and operating costs.

Company-level read

Ticker impact

$HDSNBearishHigh confidence
Context

Hudson Technologies reported Q2 revenue of $78.3M, margin compression to 26%, and revised full-year 2026 gross margin target to low-to-mid 20s.

Expected impact

Likely negative bias for the stock on guidance and margin trajectory, with volatility around the conference call.

Evidence & confidence

The filing includes specific quarterly results and a revised full-year gross margin target tied to subdued refrigerant pricing and inflationary fuel costs, which are direct drivers of earnings power.

Market effects

Signals continued pressure in refrigerant pricing and cost inflation for refrigerant reclaimers, potentially affecting peers’ margin expectations.

Limited, as the disclosure is company-specific (Illinois tornado restoration and partnership).

Low, unless refrigerant market pricing weakness is broad across regions.

Counterpoint

Despite margin compression, the company highlights double-digit trailing-twelve-month volume growth and says tornado restoration costs are expected to be covered by insurance.

Key entities

  • Hudson Technologies, Inc.

    NASDAQ-listed refrigerant reclaimer reporting Q2 2026 results, higher costs, and a revised full-year gross margin target.

  • Icorium

    Advanced separation technology company in Kansas; Hudson intends to partner to commercialize extractive distillation technology.

Related articles

$HDSNMed

Hudson Technologies Q2 Earnings Call Highlights

Hudson Technologies (NASDAQ:HDSN) reported Q2 revenue of $78.3 million, up 8% year over year, with sales volume up 12% but average refrigerant selling price down 6%. Gross margin fell to 26% from 31% a year earlier. The company revised its FY2026 gross-margin target to the low-to-mid-20% range and said the Defense Logistics Agency re-awarded a five-year $210 million contract.

$HDSNMed

Hudson Technologies (NASDAQ:HDSN) Surprises With Q2 CY2026 Sales

Hudson Technologies (NASDAQ:HDSN) reported Q2 CY2026 revenue of $78.35 million, up 7.5% year on year and 5.6% above Wall Street estimates, according to the company. GAAP EPS was $0.12, below consensus and down from $0.23 a year earlier. Management cited selling-season growth despite HFC price weakness and inflation. Shares fell 1.5% to $6.12 after the release.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.

$JOBYMedAI 8/10

Joby Aviation Q2 Earnings Call Highlights

Joby Aviation (NYSE:JOBY) raised full-year revenue guidance to $115 million to $125 million from $105 million to $115 million. Q2 cash use was about $202 million and GAAP net loss was $245 million, including a $108 million non-cash warrant and earn-out fair value change. For 2H 2026, it expects $385 million to $415 million cash use. The company said aircraft availability is a key constraint on Blade routes and outlined manufacturing, infrastructure, and JV plans with Toyota.

$JHXMedAI 8/10

James Hardie Industries Q1 Earnings Call Highlights

James Hardie (NYSE:JHX) said about one-third of fiber-cement growth came from strategic initiatives, one-third from prior-year destocking comparisons, and the rest from price and mix. June sell-through rose 19%. Deck, Rail & Accessories sales fell 5% to $305.1M with 27.1% Adjusted EBITDA margin. Q2 net sales forecast $1.485B-$1.575B and FY2027 outlook raised; FCF Q1 was $254M and it redeemed $400M notes.

$IXMed

Orix Corp Ads Q1 Earnings Call Highlights

ORIX (NYSE: IX) discussed Q1 results and outlook on an earnings call, including potential Q3 Kioxia sale and valuation losses tied to Kioxia’s end-September share price. ORIX shifted its dividend basis to adjusted profits, targeting an interim dividend of JPY 107.27 per share and full-year JPY 187.36. It reported JPY 115.7B capital gains and about JPY 300B capital-recycling inflows, and continued a JPY 250B buyback.